Trulieve Cannabis Corp. (CSE: TRUL)

Market Cap	2.87B
Revenue (ttm)	1.59B
Net Income (ttm)	-128.56M
Shares Out	187.32M
EPS (ttm)	-0.68
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	87,129
Open	15.06
Previous Close	15.34
Day's Range	14.91 - 15.35
52-Week Range	5.22 - 20.00
Beta	1.37
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 8, 2024

About Trulieve Cannabis

Trulieve Cannabis Corp., together with its subsidiaries, operates as a cannabis retailer. The company cultivates, processes, and manufactures cannabis products and distributes its products to its dispensaries, as well as through home delivery. It sells flowers, edibles, vapes, creams, balms, salves, lotions, vaporizers, batteries, cartridge, concentrates, topicals, capsules, synringes, tinctures, and accessories under the Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, Loveli, Trekkers, and Roll One bran...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1940
• Employees: 5,400
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: TRUL

Financial Performance

In 2023, Trulieve Cannabis's revenue was $1.13 billion, a decrease of -7.31% compared to the previous year's $1.22 billion. Losses were -$526.80 million, 114.1% more than in 2022.

Financial numbers in USD